OOIR: Observatory of International Research

Papers

(The median citation count of Current Opinion in Virology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Editorial Board	55
A novel antiviral strategy by disrupting the equilibrium of virus-host calcium homeostasis	54
Adenoviral-vectored next-generation respiratory mucosal vaccines against COVID-19	39
Hepatitis-B virus: replication cycle, targets, and antiviral approaches	37
Colonization of peripheral ganglia by herpes simplex virus type 1 and 2	36
Inhaled aerosol viral-vectored vaccines against tuberculosis	35
Transmission patterns of hepatitis E virus	34
The enigmatic roles of Anelloviridae and Redondoviridae in humans	33
Editorial Board	31
Editorial overview: Viral pathogenesis	30
Human placental models for studying viral infections	28
Viral–host interactions during splicing and nuclear export of influenza virus mRNAs	26
Emerging technologies in the study of the virome	24
Editorial Board	24
Paramyxoviruses from bats: changes in receptor specificity and their role in host adaptation	23
The two faces of oligoadenylate synthetase-like: effective antiviral protein and negative regulator of innate immunity	22
Intercellular highways of viral spread: tunneling nanotubes and extracellular vesicles at the maternal–fetal interface	22
A review of broadly protective monoclonal antibodies to treat Ebola virus disease	21
The enigma of picobirnaviruses: viruses of animals, fungi, or bacteria?	20
A complex immune communication between eicosanoids and pulmonary macrophages	20
Role of mucosal-associated invariant T cells in coronavirus disease 2019 vaccine immunogenicity	19
Editorial Board	19
Retasking of canonical antiviral factors into proviral effectors	19
Hemagglutinin stability as a key determinant of influenza A virus transmission via air	19
Blood virome research in myalgic encephalomyelitis/chronic fatigue syndrome: challenges and opportunities	18

Asymmetry in icosahedral viruses	18
Does arbovirus emergence in humans require adaptation to domestic mosquitoes?	18
Human organoid models to study coronavirus infections of the respiratory tract	18
Tissue-resident memory T cells in protective immunity to influenza virus	17
Oncogenic Animal Herpesviruses	17
Nexus of virus and brain: recent advances in flavivirus and enterovirus neuro-infection	17
Diagnosis and monitoring of virus-associated cancer using cell-free DNA	17
Severe fever with thrombocytopenia syndrome virus NSs: a multifaceted viral protein in host–virus interactions	17
Deimmunization of flagellin adjuvant for clinical application	17
State-of-the-art in oncolytic virotherapy using adenoviruses other than the commonly applied adenovirus type 5	17
Nucleoside analogs for management of respiratory virus infections: mechanism of action and clinical efficacy	16
MicroRNA-mediated control of Epstein–Barr virus infection and potential diagnostic and therapeutic implications	16
Role of the viral polymerase during adaptation of influenza A viruses to new hosts	16
MEK inhibitors as novel host-targeted antivirals with a dual-benefit mode of action against hyperinflammatory respiratory viral diseases	15
Modeling zoonotic and vector-borne viruses	15
Sequence variability of the K1 gene in Kaposi’s sarcoma-associated herpesvirus and its role in pathogenesis	15
Broadly neutralizing antibodies against COVID-19	14
Antigenic evolution of SARS coronavirus 2	14
Fruit bats as natural reservoir of highly pathogenic henipaviruses: balance between antiviral defense and viral tolerance	13
Early signaling pathways in virus-infected cells	12
Editorial Board	12
Editorial Board	12
Editorial overview: Special issue on phage therapy	11
Bacteriophage T4 as a nanovehicle for delivery of genes and therapeutics into human cells	11
Editorial overview: Anti-viral strategies: Human antibody immune response and antibody-based therapy against viruses	10
Human autoantibodies against type I interferons in severe viral disease	10
Antiviral restriction factors of bats: the front line of a critical reservoir of zoonotic viruses	10
Structural insights into hepatitis C virus neutralization	10
Advances in the treatment of HTLV-1-associated adult T-cell leukemia lymphoma	9
Predisposition to viral infection of the fetus and neonate	9
Editorial overview: Virus structure and expression	9
Lying low-chromatin insulation in persistent DNA virus infection	8
Editorial Board	8
Clinical and mechanistic insights into Brucella and viral co-infection	8
Koala retrovirus and neoplasia: correlation and underlying mechanisms	8
Editorial overview: Viruses and cancer — challenges, breakthroughs, and future directions	7
Editorial overview: Antiviral Strategies and Counter Measures (2025)	7
Editorial Board	7
Editorial Board	7
Host-targeted antivirals as broad-spectrum inhibitors of respiratory viruses	7
Therapeutic approaches to Epstein–Barr virus cancers	6
The role of human lipoproteins for hepatitis C virus persistence	6
The more the merrier? Gene duplications in the coevolution of primate lentiviruses with their hosts	6
Bridging the gap: ex vivo human skin explants for mechanistic studies of arboviruses	5
New directions in the multifunctionality of RNA viruses: insights from the rabies virus P-protein	5
Editorial overview: 2022 “Virus–Host Interaction” section of Current Opinion in Virology	5
Editorial Board	5
A comparative review of adenovirus A12 and C5 oncogenes	5
Beyond the liver: the broadened tissue tropism of hepatitis E virus	5
Ex vivo culture models to study viral infections of the liver	5

Status of advanced respiratory syncytial virus antiviral therapeutics 2025	4
Pathogenesis of severe acute respiratory syndrome coronavirus-2 in nonhuman primates	4
Co-opted membranes, lipids, and host proteins: what have we learned from tombusviruses?	4
Mechanisms of mucosal immunity at the female reproductive tract involved in defense against HIV infection	4
Viral determinants influencing intra- and intercellular communication in cytomegalovirus infection	4
Proteomic analysis of antiviral innate immunity	4